Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance - CNBC
Source:CNBC
Early signs from the launch of Novo Nordisk’s Wegovy pill and Eli Lilly & Co.’s Foundayo are making investors rethink the opportunity for GLP-1 pills.
Related Articles
Flight out of Nashville diverted, person removed due to ‘security matter,’ officials say - WKRN News 2
A person was removed from a flight out of Nashville Friday night after the plane landed early in …
Jobless claims point to a more stable labor market - MarketWatch
A bots-only social network triggers fears of an AI uprising - The Washington Post
Some experts are awed and others derisive over AI bots’ conversations on the new site Moltbook.
Dow Slides as Stagflation Worries Roil Markets - Barron's
The Dow, S&P 500, and Nasdaq are falling as the stock market digests disappointing jobs data and …